Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Oct 2016 for Vitae Pharmaceuticals, Inc, €4.4M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Richard Gregg: trading record in brief
Richard Gregg discloses dealings in Vitae Pharmaceuticals, Inc to SEC (Form 4). Between 13 November 2015 and 25 October 2016, the trades on record add up to 10 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 25 October 2016, the filings show a transaction worth €4.4M in Vitae Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard Gregg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
228,274 shares@ US$21.0087.9% of flowCommon StockSEC:0001104659-16-151956:0
87,301 shares@ US$3.916.2% of flowCommon StockSEC:0001104659-16-151388:0
29,657 shares@ US$7.133.8% of flowCommon StockSEC:0001104659-16-151388:1
6,944 shares@ US$14.401.8% of flowCommon StockSEC:0001104659-16-151388:2
2,100 shares@ US$6.110.2% of flowCommon StockSEC:0001104659-16-140287:0
15,000 sharesCommon StockSEC:0001104659-16-091217:0
65,089 shares@ US$3.91Common StockSEC:0001104659-15-079666:0
13,695 shares@ US$3.91Common StockSEC:0001104659-15-079666:1
6,773 shares@ US$6.90Common StockSEC:0001104659-15-079666:2
15,000 shares@ US$3.91Common StockSEC:0001104659-15-079666:3
10 of 10 declarations
